Podcast thumbnail for SBOC
127 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇧🇷

Podcast Overview

Podcast by SBOC

Language

🇵🇹

Publishing Since

3/13/2020

1 verified contact email on file for SBOC

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Evidência, acesso e sustentabilidade: o debate sobre pembrolizumabe para o SUS

May 28, 2026

Evidência, acesso e sustentabilidade: o debate sobre pembrolizumabe para o SUS

A Conitec está com 4 consultas públicas abertas para avaliar a incorporação do medicamento para tratamento de câncer de pulmão, de colo do útero, de mama e de carcinoma de esôfago. Especialistas da SBOC comentam sobre o tema! Participam: Dra. Maria Ignez Braghiroli (Comitê de Tumores Gastrointestinais Altos) Dra. Sofia Vidaurre (Comitê de Tumores Torácicos) Dra. Renata Bonadio (Comitê de Tumores Mamários) Dr. Eduardo Paulino (Comitê de Tumores Ginecológicos) Dr. André Sasse (Diretoria SBOC) Dra. Marisa Madi (Diretora Executiva da SBOC)

Episode thumbnail for Acesso e barreiras da prática oncológica fora dos grandes centros

May 22, 2026

Acesso e barreiras da prática oncológica fora dos grandes centros

A diretora da SBOC Dra. Danielle Laperche, que atua em Goiânia (GO), e o membro do Comitê de Políticas Públicas da Sociedade Dr. William Fuzita, oncologista clínico em Manaus (AM), debatem como funciona o acesso e quais são as barreiras da prática oncológica fora dos grandes centros do Brasil.

Episode thumbnail for Uso dos análogos do GLP-1 ("canetas emagrecedoras") na oncologia

May 14, 2026

Uso dos análogos do GLP-1 ("canetas emagrecedoras") na oncologia

Neste episódio, a nutróloga e coordenadora do Comitê Multiprofissional da SBOC, Dra. Andrea Pereira, recebe o oncologista Dr. Mauro Donadio e a farmacêutica e membro do Comitê Multiprofissional da SBOC Dra. Islânia Brandão para discutir o tema "Uso dos análogos do GLP-1 ("canetas emagrecedoras") na oncologia".

127 total episodes available

Deep-dive analytics for SBOC

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is SBOC?

Podcast by SBOC

How often does this podcast release new episodes?

This podcast updates weekly.

Where can I listen to this podcast?

This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.